A Post-Authorization, Long-term Study of Ozanimod Real-world Safety

NCT05605782 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

9000

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Sponsor

Bristol-Myers Squibb